Tinea Pedis Treatment Market - Forecast(2021 - 2026)

Report Code: HCR 53221 Report Format: PDF + Excel (Delivery in 48 Hrs)

Tinea Pedis Treatment Market Overview

Tinea Pedis Treatment Market size is $929.01m in 2019, and is estimated grow at a CAGR of 3.2% during the forecast period 2020-2025. Tinea pedis is a fungal infection of the foot caused by dermatophyte fungus such as Trichophyton rubrum, Trichophyton mentagrophytes and Epidermophyton floccosum, and is particularly prevalent in hot, tropical, urban environments. The patients with tinea pedis mostly suffer from itchy, intertriginous dermatitis of the toes characterized by maceration, peeling and fissuring. The increase in the incidence of fungal infections, rising awareness and incremental health care expenditure enable the pharmaceuticals to penetrate more into the Tinea Pedis Treatment Market, and thus, driving the development of the industry. 

Report Coverage

The report: “Tinea Pedis Treatment Market – Forecast (2020-2025)”, by IndustryARC covers an in-depth analysis of the following segments of the Tinea Pedis Treatment Market. 
By Disease Type: Interdigital Tinea Pedis, Moccasin Tinea Pedis and Vesicular Tinea Pedis
By Route Administration: Topical and Oral
By Distribution channel: Retail Pharmacies, Online Pharmacies and Hospitals
By Geography: North America, Europe, Asia-Pacific and Rest of the World.

Key Takeaways

  • Increasing number of people, specifically, sportsperson suffering from tinea pedis, and thus the need for buying medicines through retail pharmacies and hospitals are propelling the demand of tinea pedis treatment across the world in the upcoming years.
  • North America dominated the Tinea Pedis Treatment Market, and is estimated to record the fastest growth rate during the forecast period 2020-2025, owing to tactical initiatives by the leading pharmaceutical companies and supportive healthcare policies.
  • Detailed analysis of the Strength, Weakness and Opportunities of the prominent players operating in the market will be provided in the Tinea Pedis Treatment Market report.

By Disease Type - Segment Analysis

Based on Disease Type, Tinea Pedis Treatment Market is segmented into Interdigital Tinea Pedis, Moccasin Tinea Pedis and Vesicular Tinea Pedis. In 2019, Interdigital Tinea Pedis segment dominated the Tinea Pedis Treatment Market owing to more aggressive clinical representation.  Interdigital tinea pedis is the most common form that is caused by T. rubrum, occurs in the fourth and fifth toe web spaces, and sometimes, aggravated to the entire foot. Furthermore, the moccasin tinea pedis segment is anticipated to witness a comparatively higher growth rate during the forecast years 2020-2025 owing to new advancements and innovative products set to drive the market’s growth. 

By Route Administration Type - Segment Analysis

Based on Route Administration Type, Tinea Pedis Treatment Market is categorized into Topical and Oral. In 2019, Topical medications dominated the Tinea Pedis Treatment Market owing to widely used treatment like terbinafine spray to treat tinea pedis. Recognized as the primary treatment option for tinea pedis, Topical medications include spray, gel, lotion, powder, and others are extensively practiced as the topical medication. Also, Topical medication is set to be the fastest growing with a CAGR of 4.2% during the forecast period 2020-2025. This is owing to its ease of spread ability over effected area.

Geography - Segment Analysis

In 2019, North America dominated Tinea Pedis Treatment Market in terms of revenue with a market share of 41%, owing towards supportive healthcare policies, the large number of patients, presence of key players and well-established healthcare infrastructure.  Asia Pacific is anticipated to register a significant growth over the forecast period 2020-2025 owing to rapidly growing number of patient population with athlete’s foot, large number of retail pharmacies stores, and improving health care infrastructure. 

Drivers – Tinea Pedis Treatment Market 

  • High prevalence and rise in incidence rates of tinea pedis

The global tinea pedis treatment market is primarily driven by high prevalence and rise in incidence rates of tinea pedis across the globe. Therefore, Increasing cases of infectious diseases such as bacterial infections, fungal infections and viral infections are encouraging market players to increase their R&D efforts in this field. Simultaneously, a recent trend in the global market for tinea pedis treatment is introduced pertinent to the application of combination therapy for the treatment of foot-related fungal infections, and is anticipated to drive the market’s growth. 

Challenges – Tinea Pedis Treatment Market

  • Lack of awareness of the treatment and Side effects of antifungal drugs

Lack of awareness among the people regarding the treatment of tinea pedis in low developing countries and unavailability of proper medications, along with professional doctors is poised to slow down the growth of the market. 


Tinea Pedis Treatment Market Outlook 

Product Launches was the key strategy of the players in the Tinea Pedis Treatment Market. Tinea Pedis Treatment Market top 10 companies include Bayer AG, Galderma S.A, GlaxoSmithKline plc, Janssen Pharmaceutica, Bausch Health Company, Teva Pharmaceuticals, Sun Pharmaceuticals, Almirall, Glenmark and Cardinal Health. 

Acquisitions/Product Launches

  • In August 2020, Teva Pharmaceuticals collaborated with Douglas Pharmaceuticals America Ltd, Novum Pharmaceutical Research Services and ACM Global Laboratories to observe KETOCONAZOLE cream for treating tinea pedis. 
  • In November, 2018 Sun Pharmaceuticals Ltd has brought Japanese Drug maker Polo Pharma which is engaged in manufacturing, sales and distribution of branded and generic products particularly in Dermatology. 

1. Tinea Pedis Treatment Market Overview
    1.1 Definitions and Scope
2. Tinea Pedis Treatment Market - Executive Summary
    2.1 Market Revenue and Key Trends 
    2.2 Key trends by Disease Type
    2.3 Key trends by Route Administration 
    2.4 Key trends by Distribution Channel
    2.5 Key trends by Geography
3. Tinea Pedis Treatment Market – Comparative Analysis
    3.1 Product Benchmarking – Key Companies
    3.2 Financial Analysis – Key Companies
    3.3 Market Value Split by Key Companies
    3.4 Patent Analysis – Key Companies
    3.5 Pricing Analysis
4. Tinea Pedis Treatment Market - Startup Companies Scenario Premium
    4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Venture Capital and Funding Scenario
5. Tinea Pedis Treatment Market – Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Tinea Pedis Treatment Market Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters Five Force Model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes 
7. Tinea Pedis Treatment Market – Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Tinea Pedis Treatment Market – By Disease Type (Market Size –$Million/$Billion)
    8.1 Interdigital Tinea Pedis
    8.2 Moccasin Tinea Pedis
    8.3 Vesicular Tinea Pedis
9. Tinea Pedis Treatment Market – By Route Administration (Market Size –$Million/$Billion)
    9.1 Topical
        9.1.1 Spray
        9.1.2 Gel 
        9.1.3 Lotion
        9.1.4 Powder
        9.1.5 Others
    9.2 Oral
10. Tinea Pedis Treatment Market – By Distribution Channel (Market Size –$Million/$Billion)
    10.1 Retail Pharmacies
    10.2 Online Pharmacies
    10.3 Hospitals
11. Tinea Pedis Treatment Market - By Geography (Market Size –$Million/$Billion)
    11.1 North America
        11.1.1 U.S.
        11.1.2 Canada
        11.1.3 Mexico
    11.2 Europe
        11.2.1 U.K.
        11.2.2 Germany
        11.2.3 France
        11.2.4 Italy
        11.2.5 Spain
        11.2.6 Rest of Europe
    11.3 Asia-Pacific
        11.3.1 China
        11.3.2 Japan
        11.3.3 South Korea
        11.3.4 India
        11.3.5 Australia & New Zealand
        11.3.6 Rest of Asia-Pacific
    11.4 Rest of the World
        11.4.1 Middle East
        11.4.2 Africa
        11.4.3 South America
12. Tinea Pedis Treatment Market - Entropy
13. Tinea Pedis Treatment Market – Industry/Segment Competition Landscape   Premium 
    13.1 Market Share Analysis
        13.1.1 Global Market Share – Key Companies
        13.1.2 Market Share by Region – Key companies
        13.1.3 Market Share by Countries – Key Companies
        13.1.4 Best Practices for Companies
14. Tinea Pedis Market – Key Company List by Country Premium Premium
15. Tinea Pedis Treatment Market Company Analysis
    15.1 Bayer AG
    15.2 Galderma S.A
    15.3 GlaxoSmithKline plc
    15.4 Janssen Pharmaceutica
    15.5 Bausch Health Company
    15.6 Teva Pharmaceuticals
    15.7 Sun Pharmaceuticals
    15.8 Almirall
    15.9 Glenmark
    15.10 Cardinal Health
"*Financials for private companies would be provided on a best efforts basis”.

List of Tables

1 US Tinea Pedis Treatment Market Size 2018
2 Canada Tinea Pedis Treatment Market Share 2018
3 Brazil Tinea Pedis Treatment Market Outlook 2019 - 2023
4 Mexico Tinea Pedis Treatment Market Research 2018
5 Germany Tinea Pedis Treatment Market Trends 2019 - 2023 
6 France Tinea Pedis Treatment Market Growth 2019 - 2023 
7 UK Tinea Pedis Treatment Market Demand 2019 - 2023 
8 Italy Tinea Pedis Treatment Market Segmentation 2018
9 Russia Tinea Pedis Treatment Market Analysis 2019 - 2023
10 China Tinea Pedis Treatment Market Revenue 2019 - 2023
11 Japan Tinea Pedis Treatment Market Volume 2019 - 2023
12 South Korea Tinea Pedis Treatment Market Potential 2019 - 2023
13 India Tinea Pedis Treatment Market Leaders 2018
14 Saudi Arabia Tinea Pedis Treatment Market Forecast 2019 - 2023 
15 Kuwait Tinea Pedis Treatment Market Value 2018

List of Figures

For complete list of 60+ tables and 60+ figures follow the Link